{"id":"https://openalex.org/W2090777784","doi":"https://doi.org/10.1097/jcp.0b013e31825d9958","title":"Early Switch Strategy in Patients With Major Depressive Disorder: A Double-Blind, Randomized Study","display_name":"Early Switch Strategy in Patients With Major Depressive Disorder: A Double-Blind, Randomized Study","publication_year":2012,"publication_date":"2012-06-20","ids":{"openalex":"https://openalex.org/W2090777784","doi":"https://doi.org/10.1097/jcp.0b013e31825d9958","mag":"2090777784","pmid":"https://pubmed.ncbi.nlm.nih.gov/22722513"},"language":"en","primary_location":{"id":"doi:10.1097/jcp.0b013e31825d9958","doi":"https://doi.org/10.1097/jcp.0b013e31825d9958","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0b013e31825d9958","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001555041","display_name":"Irene Romera","orcid":"https://orcid.org/0000-0002-1345-9799","observed_orcids":["https://orcid.org/0000-0002-1345-9799"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4210128228","display_name":"Eli Lilly (Spain)","ror":"https://ror.org/033911096","country_code":"ES","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210128228"]}],"countries":["ES","SE"],"is_corresponding":true,"raw_author_name":"Irene Romera","raw_affiliation_strings":["Clinical Research Physician Neuroscience, Medical Department, Eli Lilly and Company, Madrid, Spain. romera_irene@lilly.com","Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden","Eli Lilly and Company, Madrid","Eli Lilly and Company, Solna","Universidad Aut\u00f3noma de Barcelona, Departamento de Psiquiatr\u00eda"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Physician Neuroscience, Medical Department, Eli Lilly and Company, Madrid, Spain. romera_irene@lilly.com","institution_ids":["https://openalex.org/I4210128228"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Eli Lilly and Company, Madrid","institution_ids":[]},{"raw_affiliation_string":"Eli Lilly and Company, Solna","institution_ids":[]},{"raw_affiliation_string":"Universidad Aut\u00f3noma de Barcelona, Departamento de Psiquiatr\u00eda","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051648227","display_name":"V\u00edctor P\u00e9rez","orcid":"https://orcid.org/0000-0002-5825-2337","observed_orcids":["https://orcid.org/0000-0002-5825-2337"]},"institutions":[{"id":"https://openalex.org/I2801795740","display_name":"Hospital de Sant Pau","ror":"https://ror.org/059n1d175","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2801795740"]},{"id":"https://openalex.org/I4210090703","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","ror":"https://ror.org/009byq155","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210090703","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210128228","display_name":"Eli Lilly (Spain)","ror":"https://ror.org/033911096","country_code":"ES","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210128228"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Victor P\u00e9rez","raw_affiliation_strings":["Eli Lilly and Company, Madrid, Spain","Hospital de Sant Pau i de la Santa Creu. UAB, CIBERSAM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Madrid, Spain","institution_ids":["https://openalex.org/I4210128228"]},{"raw_affiliation_string":"Hospital de Sant Pau i de la Santa Creu. UAB, CIBERSAM","institution_ids":["https://openalex.org/I2801795740","https://openalex.org/I4210090703"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086084955","display_name":"Jos\u00e9 Manuel Mench\u00f3n","orcid":"https://orcid.org/0000-0002-6231-6524","observed_orcids":["https://orcid.org/0000-0002-6231-6524"]},"institutions":[{"id":"https://openalex.org/I2802050225","display_name":"Bellvitge University Hospital","ror":"https://ror.org/00epner96","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210090703","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","ror":"https://ror.org/009byq155","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210090703","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Manuel Mench\u00f3n","raw_affiliation_strings":["Hospital Universitari de Bellvitge-IDIBELL, University of Barcelona. CIBERSAM, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari de Bellvitge-IDIBELL, University of Barcelona. CIBERSAM, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210090703","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048043719","display_name":"Alexander Schacht","orcid":"https://orcid.org/0000-0001-9516-6262","observed_orcids":["https://orcid.org/0000-0001-9516-6262"]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alexander Schacht","raw_affiliation_strings":["Eli Lilly and Company, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019996650","display_name":"Rita Papen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rita Papen","raw_affiliation_strings":["Eli Lilly and Company, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026862834","display_name":"Doris Neuhauser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doris Neuhauser","raw_affiliation_strings":["Eli Lilly and Company, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Vienna, Austria","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044681586","display_name":"Mocrane Abbar","orcid":"https://orcid.org/0000-0001-7394-0368","observed_orcids":["https://orcid.org/0000-0001-7394-0368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mocrane Abbar","raw_affiliation_strings":["H\u00f4spital Car\u00e9meau, N\u00eemes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4spital Car\u00e9meau, N\u00eemes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038445300","display_name":"P\u00e4r Svanborg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["ES","SE"],"is_corresponding":true,"raw_author_name":"P\u00e4r Svanborg","raw_affiliation_strings":["Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden","Eli Lilly and Company, Madrid","Eli Lilly and Company, Solna","Universidad Aut\u00f3noma de Barcelona, Departamento de Psiquiatr\u00eda"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Eli Lilly and Company, Madrid","institution_ids":[]},{"raw_affiliation_string":"Eli Lilly and Company, Solna","institution_ids":[]},{"raw_affiliation_string":"Universidad Aut\u00f3noma de Barcelona, Departamento de Psiquiatr\u00eda","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063639716","display_name":"Inmaculada Gilaberte","orcid":"https://orcid.org/0000-0002-3811-9811","observed_orcids":["https://orcid.org/0000-0002-3811-9811"]},"institutions":[{"id":"https://openalex.org/I2801795740","display_name":"Hospital de Sant Pau","ror":"https://ror.org/059n1d175","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2801795740"]},{"id":"https://openalex.org/I4210090703","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","ror":"https://ror.org/009byq155","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210090703","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210128228","display_name":"Eli Lilly (Spain)","ror":"https://ror.org/033911096","country_code":"ES","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210128228"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Inmaculada Gilaberte","raw_affiliation_strings":["Eli Lilly and Company, Madrid, Spain","Hospital de Sant Pau i de la Santa Creu. UAB, CIBERSAM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Madrid, Spain","institution_ids":["https://openalex.org/I4210128228"]},{"raw_affiliation_string":"Hospital de Sant Pau i de la Santa Creu. UAB, CIBERSAM","institution_ids":["https://openalex.org/I2801795740","https://openalex.org/I4210090703"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5001555041","https://openalex.org/A5038445300"],"corresponding_institution_ids":["https://openalex.org/I123044942","https://openalex.org/I28166907","https://openalex.org/I4210128228"],"apc_list":null,"apc_paid":null,"fwci":2.5861,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.8804719,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"32","issue":"4","first_page":"479","last_page":"486"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9079999923706055},{"id":"https://openalex.org/keywords/antidepressant-switching","display_name":"antidepressant switching","score":0.8989999890327454},{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/escitalopram","display_name":"escitalopram","score":1.0},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.6650000214576721},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.796999990940094},{"id":"https://openalex.org/keywords/time-to-response","display_name":"time to response","score":0.7279999852180481},{"id":"https://openalex.org/keywords/antidepressant-non-response","display_name":"antidepressant non-response","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2779583969","wikidata":"https://www.wikidata.org/wiki/Q423757","display_name":"Escitalopram","level":4,"score":0.9745916724205017},{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.7849565744400024},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.6804426908493042},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6267849802970886},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5419304370880127},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.5198872089385986},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5022299289703369},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5006389617919922},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.4694257378578186},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.4325698912143707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4314262866973877},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.382857084274292},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3497656583786011},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3460184335708618},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.16650882363319397},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.06803923845291138},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015283","descriptor_name":"Citalopram","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061218","descriptor_name":"Depressive Disorder, Treatment-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/jcp.0b013e31825d9958","doi":"https://doi.org/10.1097/jcp.0b013e31825d9958","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0b013e31825d9958","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:22722513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22722513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320322930","display_name":"Ministerio de Ciencia e Innovaci\u00f3n","ror":null},{"id":"https://openalex.org/F4320334810","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra","ror":"https://ror.org/02rxc7m23"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W2000209756","https://openalex.org/W2018008180","https://openalex.org/W2021744708","https://openalex.org/W2061378977","https://openalex.org/W2063291862","https://openalex.org/W2068890247","https://openalex.org/W2093713985","https://openalex.org/W2099564543","https://openalex.org/W2107695086","https://openalex.org/W2114613490","https://openalex.org/W2149402043","https://openalex.org/W2150791768","https://openalex.org/W2163997752","https://openalex.org/W2917243324","https://openalex.org/W7214234489"],"related_works":["https://openalex.org/W1993556404","https://openalex.org/W2256483584","https://openalex.org/W2018725567","https://openalex.org/W2913434025","https://openalex.org/W2043274559","https://openalex.org/W2560015842","https://openalex.org/W2077992359","https://openalex.org/W2767702990","https://openalex.org/W2735979276","https://openalex.org/W2090313686"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Antidepressant":[1],"switch":[2,33,71,86,110,218,248,263],"is":[3,18],"a":[4,30,239],"commonly":[5],"used":[6],"strategy":[7,34,72,87,264],"in":[8,35,50,100,108,123,177,232],"the":[9,24,233,246,258],"absence":[10],"of":[11,26,102,152,154,204],"an":[12,27],"adequate":[13],"response,":[14],"but":[15],"optimum":[16],"timing":[17],"not":[19],"well":[20],"established.":[21],"We":[22],"compared":[23,140],"efficacy":[25],"early":[28,70,217,247],"and":[29,133,145,161],"conventional":[31,85,259],"antidepressant":[32,262],"patients":[36,155,214],"with":[37,43,73,245],"major":[38],"depressive":[39],"disorder.":[40],"METHODS:":[41],"Patients":[42],"no":[44,157,230],"or":[45,84,120,158,169,192],"minimal":[46,159],"improvement":[47,160],"(<30%":[48],"reduction":[49,107],"baseline":[51],"17-item":[52],"Hamilton":[53],"Depression":[54],"Rating":[55],"Scale":[56],"[HAMD17]":[57],"score)":[58],"after":[59],"4":[60,90],"weeks":[61,81,92],"on":[62,93],"escitalopram":[63,94,122],"10":[64,95],"mg/d":[65,78,116],"were":[66,128,139,162,201,207,237],"randomized":[67,163,215],"to":[68,76,96,111,114,130,164,179,216,256,261],"either":[69],"duloxetine":[74,112],"60":[75,113],"120":[77,115],"for":[79,117],"12":[80],"(arm":[82,88],"A)":[83],"B):":[89],"further":[91,254],"20":[97],"mg/d;":[98],"then,":[99],"case":[101],"nonresponse":[103],"(response,":[104],"\u2265":[105],"50%":[106],"HAMD17),":[109],"8":[118],"weeks,":[119,188,197],"continued":[121],"responders.":[124],"Co-primary":[125],"end":[126,235],"points":[127,236],"time":[129,178],"confirmed":[131,180,205,220],"response":[132,181],"remission":[134,193,221,241],"(HAMD17,":[135],"\u2264":[136],"7).":[137],"Strategies":[138],"using":[141],"Kaplan-Meier,":[142],"logistic":[143],"regression,":[144],"repeated-measures":[146],"analyses.":[147],"RESULTS:":[148],"Sixty-seven":[149],"percent":[150],"(566":[151],"840)":[153],"showed":[156],"arm":[165,170],"A":[166],"(282":[167],"patients)":[168],"B":[171],"(284":[172],"patients).":[173],"No":[174],"between-strategy":[175],"differences":[176,231],"(25%":[182],"Kaplan-Meier":[183],"estimates,":[184],"3.9":[185],"vs":[186,195,210,223],"4.0":[187],"P":[189,198,225],"=":[190,199,226],"0.213)":[191],"(6.0":[194],"7.9":[196],"0.075)":[200],"found.":[202],"Rates":[203],"responders":[206],"similar":[208],"(64.9%":[209],"64.1%);":[211],"however,":[212],"more":[213],"achieved":[219],"(43.3%":[222],"35.6%;":[224],"0.048).":[227],"CONCLUSIONS:":[228],"Although":[229],"primary":[234],"found,":[238],"higher":[240],"rate":[242],"was":[243],"seen":[244],"strategy.":[249],"Our":[250],"findings":[251],"suggest":[252],"that":[253],"investigations":[255],"reevaluate":[257],"approach":[260],"would":[265],"be":[266],"worthwhile.":[267]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}